OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc under contract SPE2DP26F5692, issued on May 12, 2026, to supply OMEPRAZOLE EXTENDED with NSN 6505016247068. This delivery order falls under the broader contract SPE2DX25D9900 and is part of the Department of Defense’s procurement efforts to support military medical needs. The award was posted on DIBBS on July 21, 2026, and the total contract value is specified in the official award documentation. The contract is classified as a federal action with no specified set-aside or NAICS code, and the place of performance and office address details are not provided. The point of contact information is also unavailable, but the full award record can be accessed via the DIBBS online portal using the provided UI link.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
3AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
